Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium anti-inflammatory effects in stable COPD
NL-OMON55417Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium Respimat with Placebo (2 arms). Primary endpoints: Change in induced sputum interleukin-6 protein and Change in induced sputum interleukin-8 protein. Started Aug 2019; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON55417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55417.